Literature DB >> 4598259

Antibacterial activity and pharmacokinetic behavior of cefazolin as compared with five other cephalosporin antibiotics.

P Naumann, E Reintjens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4598259     DOI： 10.1007/bf01642219

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  7 in total

1.  Antibiotic sensitivity testing. Report of an international collaborative study.

Authors:  H M Ericsson; J C Sherris
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

2.  [Bacteriological and pharmacological properties of new cephalosporin antibiotics. I. Cephalothin 1].

Authors:  P Naumann
Journal:  Arzneimittelforschung       Date:  1966-07

3.  Pharmacologic study of cefazolin in volunteers.

Authors:  P De Schepper; C Harvengt; C Vranckx; B Boon; F Lamy
Journal:  J Clin Pharmacol New Drugs       Date:  1973 Feb-Mar

4.  Clinical studies of cefazolin in the surgical field.

Authors:  K Shibata; M Fujii
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

5.  Concentration of antibacterial agents in interstitial tissue fluid.

Authors:  G D Chisholm; P M Waterworth; J S Calnan; L P Garrod
Journal:  Br Med J       Date:  1973-03-10

6.  In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative.

Authors:  M Nishida; T Matsubara; T Murakawa; Y Mine; Y Yokota; S Kuwahara; S Goto
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969

7.  Absorption, tissue concentration, and organ distribution of cefazolin.

Authors:  S Ishiyama; I Nakayama; H Iwamoto; S Iwai; M Okui
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970
  7 in total
  8 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 2.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

3.  Blood, brain, and cerebrospinal fluid concentrations of several antibiotics in rabbits with intact and inflamed meninges.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

4.  [Letter: On P. Naumann's article; On the current status of standardization of resistance determination in Germany].

Authors: 
Journal:  Infection       Date:  1974       Impact factor: 3.553

5.  Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.

Authors:  A Philipson; G Stiernstedt; M Ehrnebo
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 6.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

7.  Concentrations of cefazolin in human skeletal muscle.

Authors:  E Sinagowitz; K Pelz; A Burgert; W Kaczkowski
Journal:  Infection       Date:  1976       Impact factor: 3.553

8.  [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].

Authors:  R Ratschow; J R Krone
Journal:  Infection       Date:  1977       Impact factor: 3.553
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.